Wegovy’s cash price comes from Novo Nordisk’s own pharmacy program, and it’s far below the list price. Through NovoCare Pharmacy, the pen costs $349 a month at every dose up to 2.4 mg, after an intro price of $199 for new patients [1]. The pill starts at $149. Insurance, the savings card and Medicare’s new GLP-1 Bridge can each change that number, as long as you know which one applies to you.
Which Wegovy price applies to you
| Situation | Price | Conditions | Source |
|---|---|---|---|
| Cash, pen, new patient, 0.25 or 0.5 mg | $199 a month | First 2 monthly fills, through December 31, 2026 | NovoCare [1] |
| Cash, pen, 0.25 to 2.4 mg | $349 a month | After the intro fills | NovoCare [1] |
| Cash, Wegovy HD pen, 7.2 mg | $399 a month | Highest labeled dose | NovoCare [1] |
| Cash, pill, 1.5 mg | $149 a month | One 30-tablet bottle | NovoCare [1] |
| Cash, pill, 4 mg | $199 a month | One 30-tablet bottle | NovoCare [1] |
| Cash, pill, 9 or 25 mg | $299 a month | One 30-tablet bottle | NovoCare [1] |
| Commercial plan covers it, with savings card | As little as $25 | Maximum savings $100 a month | NovoCare [1] |
| Medicare GLP-1 Bridge | $50 copay | July 2026 through December 2027, eligible Part D enrollees | CMS [3] |
| TrumpRx | Pen $199, pill $149 (lowest deals) | TrumpRx shows $1,349 as the “Original Price” | TrumpRx [4] |
| Patient Assistance Program | Not available | Wegovy isn’t on the 2026 product list | Novo Nordisk [2] |
NovoCare defines a month as one box of 4 pens or one bottle of 30 tablets [1]. Prices as currently listed.
Without insurance, the pen costs $349 a month at most doses
Paying cash through NovoCare Pharmacy, the Wegovy pen costs $349 a month at 0.25, 0.5, 1, 1.7 or 2.4 mg, and $399 a month for the 7.2 mg Wegovy HD pen [1]. A month means one box of 4 pens.
New patients get a lower start. NovoCare’s terms: patients new to the offer “pay $199 for each month of 0.25 mg & 0.5 mg. Offer for 2 monthly fills through December 31, 2026, then $349 per month” [1]. That means the first two months save you $150 each, or $300 in all.
The price doesn’t climb with your dose until 7.2 mg. Someone on 2.4 mg pays what someone on 0.5 mg pays after the intro months. To get these prices, you fill through NovoCare Pharmacy or take the savings offer to your own pharmacist.
| Months | Price per month | Subtotal |
|---|---|---|
| Months 1 and 2 (intro, 0.25 or 0.5 mg) | $199 | $398 |
| Months 3 to 13 (0.25 to 2.4 mg) | $349 | $3,839 |
| Total for 13 four-pen boxes | $4,237 |
A box of 4 weekly pens lasts 4 weeks, so a year of weekly doses is 13 boxes. Assumes the intro offer applies and the dose stays at or below 2.4 mg. At 7.2 mg the monthly price is $399 [1].
Wegovy pills cost $149 to $299 a month
Wegovy tablets cost $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg or 25 mg, where a month is one 30-tablet bottle [1]. Unlike the pen, the pill’s price rises with the dose. More on how the pill differs is on the oral semaglutide page.
The $1,349 figure is a list price almost nobody pays
TrumpRx shows $1,349 as Wegovy’s “Original Price,” next to its own deals of $199 for the pen and $149 for the pill (TrumpRx) [4]. Those deal prices match NovoCare’s starting prices. The cash payer’s real price is NovoCare’s offer, not the list figure.
Insurance coverage depends on your plan and the reason it’s prescribed
Whether insurance covers Wegovy depends on your plan’s formulary (its covered-drug list), not on your insurer’s name. Coworkers and neighbors with the same insurer may hear different answers, because employers choose different plans, and an employer can decide whether its plan covers weight-loss drugs.
The reason for the prescription can matter too. Wegovy’s label covers three uses [7]. One is cutting the risk of heart attack, stroke and cardiovascular death in adults who have heart disease plus obesity or overweight. Another is weight management over the long term. The third, under accelerated approval, is MASH, a fatty liver disease, with moderate to advanced scarring. Ask your plan how it treats each use.
| Step | What to ask | Why |
|---|---|---|
| 1 | Is Wegovy on my plan’s formulary, and at what tier? | The formulary decides coverage and your copay |
| 2 | Does it need prior authorization? | The plan may need your prescriber to justify it first |
| 3 | Does my plan exclude drugs used for weight loss? | Some plans cover only other uses |
| 4 | What records does it need, such as BMI or a heart-disease diagnosis? | The plan may ask your prescriber to send them |
| 5 | Do I have to try another drug first (step therapy)? | Some plans require it |
With coverage, the savings card can bring Wegovy to $25
If your commercial insurance covers Wegovy, the savings offer lets you “pay as little as $25, subject to a maximum savings of $100/month” [1]. The cap is the catch. If your plan leaves you $300 to pay, the card takes off $100 and you still owe $200. On a high-deductible plan, that can mean paying more than the $349 cash price until you meet your deductible.
The $25 copay is for commercial, non-government insurance. NovoCare adds that government-insured patients “may use this program if they self pay and process outside of their insurance” [1]. In other words, someone on Medicare can still pay the cash price, just not the $25 copay.
Medicare: the GLP-1 Bridge charges $50 a month
Part D doesn’t pay for drugs used for weight loss. The Part D statute leaves out drugs on Medicaid’s restricted list, which includes “agents when used for anorexia, weight loss, or weight gain” [5] [6].
The Medicare GLP-1 Bridge is CMS’s way around that. CMS calls it “a short-term demonstration” that gives eligible Part D enrollees access to certain GLP-1 drugs “between July 1, 2026, and December 31, 2027” [3]. The copay is $50. Because the Bridge runs outside Part D, your deductible is skipped, the $50 won’t count toward your yearly out-of-pocket limit, and Extra Help (the low-income subsidy) doesn’t apply.
NovoCare says eligible Medicare patients pay $50 a month for Wegovy through the Bridge, and that “this pricing is for adult patients with Medicare prescribed Wegovy for weight loss only” [1]. CMS sets the eligibility rules and runs prior authorization through a central processor [3], so check whether you qualify before counting on the $50 price.
Free Wegovy isn’t a realistic route
Wegovy isn’t on Novo Nordisk’s Patient Assistance Program product list for 2026. The list includes Ozempic, the company’s diabetes brand of semaglutide, but not Wegovy [2]. The realistic low-cost routes are the savings card with coverage, the Bridge on Medicare, and the $199 intro price if you’re paying cash.
Where you buy changes the drug price less than you think
The drug’s cash price is set by Novo’s own program. Pharmacies and telehealth programs differ mainly in what they add on top, such as a visit fee or a membership. For a store like CVS, Walmart or Costco, ask the pharmacist what it charges cash for your dose and set that against NovoCare’s $349.
6 telehealth programs on this site prescribe brand Wegovy. Two that publish a monthly figure including their own fee:
| Program | How the drug is supplied | Monthly, drug plus fee |
|---|---|---|
| AgelessRx | Pen billed through NovoCare, plus a monthly membership | $414/mo at the starting price |
Prices from each program’s own pages. Use the monthly cost calculator to work out a plan's cost at your dose.
Also offered by (no standing monthly price published): Sesame, Sesame (pill).
Will Wegovy get cheaper? The intro prices are due for an update
NovoCare says its pricing is “to be updated after December 31, 2026,” when the $199 intro offer also ends [1]. Nobody outside Novo Nordisk knows the next price, so plan around today’s $349 and check again in January.
Compounded semaglutide costs less but isn’t Wegovy, and FDA doesn’t review it before it’s sold. Its prices are in compounded semaglutide cost, and how to get it is in how to get compounded semaglutide. For the same molecule under its diabetes label, see Ozempic cost without insurance. For tirzepatide, see Zepbound cost. Safety is covered in is Wegovy safe, and the drug itself on the Wegovy and semaglutide pages.